Literature DB >> 27439494

Attenuation of hypertension and renal damage in renovascular hypertensive rats by iron restriction.

Makiko Oboshi1, Yoshiro Naito1, Hisashi Sawada1, Toshihiro Iwasaku1, Yoshitaka Okuhara1, Akiyo Eguchi1, Shinichi Hirotani1, Toshiaki Mano1, Takeshi Tsujino2, Tohru Masuyama1.   

Abstract

Iron is a catalyst in the formation of reactive oxygen species. Oxidative stress is associated with the pathogenesis of both human and experimental animal models of renovascular hypertension. We hypothesized that iron is involved in the pathogenesis of renovascular hypertension and that iron restriction may affect the pathogenesis of renovascular hypertension via the inhibition of oxidative stress. Herein, we investigated the effect of iron restriction on hypertension and renal damage in a rat model of two-kidney one-clip (2K1C) renovascular hypertension. Renovascular hypertension was induced by 2K1C in male Sprague-Dawley rats. At the day of clipping, 2K1C rats were divided into untreated (2K1C) and dietary iron-restricted groups (2K1C+IR). The 2K1C rats showed hypertension after the day of clipping, whereas dietary iron restriction attenuated the development of hypertension. Vascular hypertrophy and the increased fibrotic area were suppressed in the 2K1C+IR group. The clipped kidney developed renal atrophy in both the 2K1C and 2K1C+IR groups after clipping. However, the unclipped kidney showed renal hypertrophy in the 2K1C and 2K1C+IR groups, and the extent was less in the 2K1C+IR group. The 2K1C rats exhibited glomerulosclerosis and tubulointerstitial fibrosis in the unclipped kidney, whereas these changes were attenuated by an iron-restricted diet. Importantly, proteinuria was decreased in the 2K1C+IR group, along with decreased urinary 8-hydroxy-2'-deoxyguanosine excretion and superoxide production of the unclipped kidney. Moreover, the expression of nuclear mineralocorticoid receptor in the unclipped kidney of the 2K1C rats was attenuated by iron restriction. These data indicate a novel effect of iron restriction on hypertension and renal damage in renovascular hypertension.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27439494     DOI: 10.1038/hr.2016.93

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  21 in total

1.  Mineralocorticoid receptor antagonists for the treatment of hypertension and the metabolic syndrome.

Authors:  Bertram Pitt
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Combined Aliskiren and L-arginine treatment reverses renovascular hypertension in an animal model.

Authors:  Renata V Tiradentes; Cintia H Santuzzi; Erick Rg Claudio; Vinicius Mengal; Nyam F Silva; Henrique A F Neto; Nazaré S Bissoli; Glaucia R Abreu; Sonia A Gouvea
Journal:  Hypertens Res       Date:  2015-03-05       Impact factor: 3.872

3.  Renal artery stenosis and hypertension.

Authors:  F H Derkx; M A Schalekamp
Journal:  Lancet       Date:  1994-07-23       Impact factor: 79.321

4.  Dietary iron restriction prevents hypertensive cardiovascular remodeling in Dahl salt-sensitive rats.

Authors:  Yoshiro Naito; Shinichi Hirotani; Hisashi Sawada; Hirokuni Akahori; Takeshi Tsujino; Tohru Masuyama
Journal:  Hypertension       Date:  2011-01-24       Impact factor: 10.190

5.  Alteration of cardiac and renal functions in transgenic mice overexpressing human mineralocorticoid receptor.

Authors:  D Le Menuet; R Isnard; M Bichara; S Viengchareun; M Muffat-Joly; F Walker; M C Zennaro; M Lombès
Journal:  J Biol Chem       Date:  2001-08-08       Impact factor: 5.157

6.  Endothelial function and oxidative stress in renovascular hypertension.

Authors:  Yukihito Higashi; Shota Sasaki; Keigo Nakagawa; Hideo Matsuura; Tetsuya Oshima; Kazuaki Chayama
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

7.  Dietary iron restriction prevents further deterioration of renal damage in a chronic kidney disease rat model.

Authors:  Yoshiro Naito; Aya Fujii; Hisashi Sawada; Shinichi Hirotani; Toshihiro Iwasaku; Yoshitaka Okuhara; Akiyo Eguchi; Mitsumasa Ohyanagi; Takeshi Tsujino; Tohru Masuyama
Journal:  J Hypertens       Date:  2013-06       Impact factor: 4.844

8.  A comparison of the actions of cilazapril in normal, dietary sodium-depleted and two-kidney, one clip Goldblatt hypertensive anaesthetised rats.

Authors:  K K al-Qattan; E J Johns
Journal:  J Hypertens       Date:  1992-05       Impact factor: 4.844

9.  Reversal of two-kidney one clip renovascular hypertension in the rat.

Authors:  H Thurston; R F Bing; J D Swales
Journal:  Hypertension       Date:  1980 May-Jun       Impact factor: 10.190

10.  Stenting and medical therapy for atherosclerotic renal-artery stenosis.

Authors:  Christopher J Cooper; Timothy P Murphy; Donald E Cutlip; Kenneth Jamerson; William Henrich; Diane M Reid; David J Cohen; Alan H Matsumoto; Michael Steffes; Michael R Jaff; Martin R Prince; Eldrin F Lewis; Katherine R Tuttle; Joseph I Shapiro; John H Rundback; Joseph M Massaro; Ralph B D'Agostino; Lance D Dworkin
Journal:  N Engl J Med       Date:  2013-11-18       Impact factor: 91.245

View more
  9 in total

1.  Iron restriction in renovascular hypertension.

Authors:  Masayuki Tanemoto
Journal:  Hypertens Res       Date:  2017-03-02       Impact factor: 3.872

2.  Reply to 'Iron restriction in renovascular hypertension'.

Authors:  Yoshiro Naito; Makiko Oboshi; Tohru Masuyama
Journal:  Hypertens Res       Date:  2017-03-02       Impact factor: 3.872

3.  Altered expression of intestinal duodenal cytochrome b and divalent metal transporter 1 might be associated with cardio-renal anemia syndrome.

Authors:  Yoshiro Naito; Hisashi Sawada; Makiko Oboshi; Keisuke Okuno; Seiki Yasumura; Yoshitaka Okuhara; Akiyo Eguchi; Koichi Nishimura; Yuko Soyama; Masanori Asakura; Masaharu Ishihara; Takeshi Tsujino; Tohru Masuyama
Journal:  Heart Vessels       Date:  2017-07-01       Impact factor: 2.037

4.  Novel insights into renovascular hypertension and cardio-renal protection by iron restriction.

Authors:  Atsushi Tanaka; Koichi Node
Journal:  Hypertens Res       Date:  2016-09-08       Impact factor: 3.872

5.  The activation of the kynurenine pathway in a rat model with renovascular hypertension.

Authors:  Jacek Bartosiewicz; Tomasz Kaminski; Krystyna Pawlak; Malgorzata Karbowska; Anna Tankiewicz-Kwedlo; Dariusz Pawlak
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

6.  Factors Associated with Outcomes of Percutaneous Transluminal Renal Angioplasty in Patients with Renal Artery Stenosis: A Retrospective Analysis of 50 Consecutive Cases.

Authors:  Tetsutaro Matayoshi; Kei Kamide; Ryoichi Tanaka; Tetsuya Fukuda; Takeshi Horio; Yoshio Iwashima; Fumiki Yoshihara; Satoko Nakamura; Hajime Nakahama; Yusuke Ohya; Yuhei Kawano
Journal:  Int J Hypertens       Date:  2018-01-04       Impact factor: 2.420

7.  Iron-restricted pair-feeding affects renal damage in rats with chronic kidney disease.

Authors:  Yoshiro Naito; Aya Senchi; Hisashi Sawada; Makiko Oboshi; Tetsuo Horimatsu; Keisuke Okuno; Seiki Yasumura; Masaharu Ishihara; Tohru Masuyama
Journal:  PLoS One       Date:  2017-02-14       Impact factor: 3.240

8.  Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy.

Authors:  Alex A Gutsol; Paula Blanco; Taben M Hale; Jean-Francois Thibodeau; Chet E Holterman; Rania Nasrallah; Jose W N Correa; Sergey A Afanasiev; Rhian M Touyz; Chris R J Kennedy; Dylan Burger; Richard L Hébert; Kevin D Burns
Journal:  PLoS One       Date:  2022-02-17       Impact factor: 3.240

9.  Ferritin modifies the relationship between inflammation and arterial stiffness in hypertensive patients with different glucose tolerance.

Authors:  Angela Sciacqua; Ettore Ventura; Giovanni Tripepi; Velia Cassano; Graziella D'Arrigo; Stefanos Roumeliotis; Raffale Maio; Sofia Miceli; Maria Perticone; Francesco Andreozzi; Giorgio Sesti; Francesco Perticone
Journal:  Cardiovasc Diabetol       Date:  2020-08-05       Impact factor: 9.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.